Inventor

DUBE LAURENCE

CA9 patents

⚠️ This page may combine multiple inventors who share the name “DUBE LAURENCE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

3 patents

US10822343B2Nov 3, 2020

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO4 citations83

US10428077B2Oct 1, 2019

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO8 citations83

US10047103B2Aug 14, 2018

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO11 citations83

MERCK FROSST CANADA LTD

3 patents

US7153968B2Dec 26, 2006

8-(biaryl)quinoline PDE4 inhibitors

MERCK FROSST CANADA LTD7 citations73

US7238706B2Jul 3, 2007

4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors

MERCK FROSST CANADA LTD0 citations51

US7144896B2Dec 5, 2006

Hetero-bridge substituted 8-arylquinoline pde4 inhibitors

MERCK FROSST CANADA LTD2 citations51

MERCK FROSST CANADA

1 patent

US7482456B2Jan 27, 2009

8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors

MERCK FROSST CANADA3 citations61

BAYLY CHRISTOPHER I

1 patent

US8063105B2Nov 22, 2011

Renin inhibitors

BAYLY CHRISTOPHER I1 citations45

MERCK FROST CANADA LTD

1 patent

US7342024B2Mar 11, 2008

4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors

MERCK FROST CANADA LTD0 citations44